Breast cancer therapy for BRCA1 carriers: moving towards platinum standard?

por Imyanitov, Evgeny N
Publicado 2009

Systemic therapy for hereditary cancer

por Imyanitov, Evgeny N
Publicado 2012

Cytotoxic and targeted therapy for BRCA1/2-driven cancers

por Imyanitov, Evgeny N.
Publicado 2021

Mechanisms of acquired resistance of BRCA1/2-driven tumors to platinum compounds and PARP inhibitors

por Imyanitov, Evgeny, Sokolenko, Anna
Publicado 2021

Molecular testing for colorectal cancer: Clinical applications

por Imyanitov, Evgeny, Kuligina, Ekaterina
Publicado 2021

Integrative Genomic Tests in Clinical Oncology

por Imyanitov, Evgeny, Sokolenko, Anna
Publicado 2022

Systemic treatment for hereditary cancers: a 2012 update

por Imyanitov, Evgeny N, Byrski, Tomasz
Publicado 2013

Drug therapy for hereditary cancers

por Imyanitov, Evgeny N, Moiseyenko, Vladimir M
Publicado 2011

Cytotoxic and targeted therapy for hereditary cancers

por Iyevleva, Aglaya G., Imyanitov, Evgeny N.
Publicado 2016

Molecular Diagnostics in Clinical Oncology

por Sokolenko, Anna P., Imyanitov, Evgeny N.
Publicado 2018

Cancer Therapy Guided by Mutation Tests: Current Status and Perspectives

por Aleksakhina, Svetlana N., Imyanitov, Evgeny N.
Publicado 2021

Integration of the blood test into the low-dose computed tomography lung cancer screening: reliable discrimination between malignant and non-malignant radiographic findings

por Kuligina, Ekaterina S., Iyevleva, Aglaya G., Imyanitov, Evgeny N.
Publicado 2021

Harmonization of Molecular Testing for Non-Small Cell Lung Cancer: Emphasis on PD-L1

por Imyanitov, Evgeny N., Ivantsov, Alexandr O., Tsimafeyeu, Ilya V.
Publicado 2020

Platinum drugs and taxanes: can we overcome resistance?

por Sazonova, Elena V., Kopeina, Gelina S., Imyanitov, Evgeny N., Zhivotovsky, Boris
Publicado 2021

BRCA1-deficient breast cancer cell lines are resistant to MEK inhibitors and show distinct sensitivities to 6-thioguanine

por Gu, Yuexi, Helenius, Mikko, Väänänen, Kristiina, Bulanova, Daria, Saarela, Jani, Sokolenko, Anna, Martens, John, Imyanitov, Evgeny, Kuznetsov, Sergey
Publicado 2016

The role of intradermal proliferation of T-cells in the pathogenesis of psoriasis

por Khairutdinov, Vladislav R., Mikhailichenko, Anastasiya F., Belousova, Irena E., Kuligina, Ekatherina Sh., Samtsov, Alexey V., Imyanitov, Evgeny N.
Publicado 2017

Rapid Improvement of the Performance Status and Reduction of the Tumor Size in KRAS-Mutated Colorectal Cancer Patient Receiving Binimetinib, Hydroxychloroquine, and Bevacizumab

por Orlov, Sergey V., Urtenova, Magaripa A., Sviridenko, Maria A., Nesterov, Denis V., Sokolova, Tatiana N., Imyanitov, Evgeny N.
Publicado 2020

Development of an interactive, agent-based local stochastic model of COVID-19 transmission and evaluation of mitigation strategies illustrated for the state of Massachusetts, USA

por Kirpich, Alexander, Koniukhovskii, Vladimir, Shvartc, Vladimir, Skums, Pavel, Weppelmann, Thomas A., Imyanitov, Evgeny, Semyonov, Semyon, Barsukov, Konstantin, Gankin, Yuriy
Publicado 2021

Lack of Response to Imatinib in Melanoma Carrying Rare KIT Mutation p.T632I

por Orlova, Kristina V., Yanus, Grigory A., Aleksakhina, Svetlana N., Venina, Aigul R., Iyevleva, Aglaya G., Demidov, Lev V., Imyanitov, Evgeny N.
Publicado 2019

Hereditary cancer syndromes

por Imyanitov, Evgeny N, Kuligina, Ekaterina S, Sokolenko, Anna P, Suspitsin, Evgeny N, Yanus, Grigoriy A, Iyevleva, Aglaya G, Ivantsov, Alexandr O, Aleksakhina, Svetlana N
Publicado 2023